Cullinan Therapeutics Newsroom

Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36

Futu NewsNov 19 22:31

JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $34

Futu NewsNov 19 16:43

TD Cowen Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating

Futu NewsNov 19 16:37

Leerink Partners Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28

Futu NewsNov 19 16:36

Morgan Stanley Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $38

Futu NewsNov 8 22:31

H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28

Futu NewsNov 8 19:35

TD Cowen Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating

Futu NewsNov 8 03:31

BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 30 19:35

Cullinan Oncology Initiated at Buy by UBS

Dow JonesOct 24 19:40

UBS Initiates Cullinan Therapeutics(CGEM.US) With Buy Rating, Announces Target Price $30

Futu NewsOct 24 18:37

BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 17 19:31

Cullinan Oncology Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow JonesOct 17 02:52

Cullinan Therapeutics Analyst Ratings

BenzingaOct 17 02:42

H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28

Futu NewsOct 16 22:31

JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $29

Futu NewsOct 15 22:32

JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $29

Futu NewsSep 25 20:33

Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36

Futu NewsSep 18 20:33

Wedbush Reiterates Outperform on Cullinan Therapeutics, Maintains $36 Price Target

BenzingaSep 18 20:24

BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30

Futu NewsSep 18 19:31

Cullinan Therapeutics Analyst Ratings

BenzingaSep 17 23:12